Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Hospira Australia Pty Ltd.
WARNING LETTER
•Hospira Australia Pty Ltd.•March 1, 2014

Hospira Australia Pty Ltd. – FDA Warning Letter, Mar 1, 2014

Record Details

On September 26, 2014, the FDA issued a Warning Letter to Hospira Australia Pty, Limited, following an inspection from February 24 to March 1, 2014. The inspection revealed significant violations of Current Good Manufacturing Practice (CGMP) regulations (21 CFR Parts 210 and 211) for finished pharmaceuticals, rendering their drug products adulterated under 21 U.S.C. 351(a)(2)(B).

Key violations included: 1. **Inadequate investigation of OOS results (21 CFR 211.192):** * Failure to thoroughly investigate out-of-specification (OOS) results for an impurity in multiple batches of an injection product, despite recurring OOS values and concerns about vial-to-vial variability. The firm's investigations were deemed insufficient, and the practice of averaging individual OOS impurity values was questioned. * Failure to implement effective corrective and preventive actions for recurrent foreign matter (particles) in an injection drug product, despite investigations spanning from 2012 to 2014. No validated analytical method was established to detect these particles.

2. **Failure to establish adequate production and process controls (21 CFR 211.100(a)):** * Concerns regarding the validation of the manufacturing process related to

Company
Hospira Australia Pty Ltd.
Inspection date
March 1, 2014
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas J. Cosgrove
View Company Profile

ID · 3a8962ed-bdbd-4d71-901a-319261fb9686

Violation Codes10
21 CFR 21021 CFR 21121 CFR 211.19221 CFR 211.100(a)21 CFR 211.42(c)(10)(iv)21 CFR 211.19821 CFR 211.180(e)21 U.S.C. 356C(a)(1)21 U.S.C. 381(a)(3)FD&C Act 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Hospira Australia Pty Ltd.
  • 483 - 2022-09-02September 2, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hospira Australia Pty Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.